Compugen Ltd. has appointed Michele Holcomb, Ph.D., as an independent director to its Board of Directors, effective February 11, 2026. Dr. Holcomb brings over 30 years of experience in biotech, pharmaceuticals, and healthcare services, having previously held executive roles at Cardinal Health and Teva Pharmaceuticals. She also serves on the boards of PureTech Health plc, Kimball Electronics, Inc., and Controlant hf.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compugen Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN86736) on February 12, 2026, and is solely responsible for the information contained therein.